Institution
Jiangsu Province Hospital
Also known as: First Affiliated Hospital of Nanjing Medical University · 江苏省人民医院
- 291running trials
- 77closed trials
- 38,699publications (OpenAlex)
Running trials
Not yet recruiting
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Not yet recruiting
Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Endovascular Brain-Computer Interface for Upper-Limb Paralysis
Not yet recruiting
Not yet recruiting
Not yet recruiting
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Real-World Study of BCL-2 Inhibitor-Based Regimens in Chronic Lymphocytic Leukemia
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
A Study of T-DXd in AI-Assessed HER2-Ultralow Metastatic Breast Cancer
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR
Not yet recruiting
Sino-Russian Comparison of Outcomes After Proximal Gastrectomy With Double-Tract Reconstruction
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Recruiting
Not yet recruiting
R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
Recruiting
A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
Not yet recruiting
Recruiting
Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Epidural Spinal Cord Stimulation for Respiratory Recovery in Cervical SCI
Recruiting
Not yet recruiting
Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma
Recruiting
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
Recruiting
Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension
Recruiting
Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation
Recruiting
Not yet recruiting
Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC
Not yet recruiting
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
Not yet recruiting
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Showing 50 of 291.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer27 recruiting
- Lung cancer18 recruiting
- Chronic lymphocytic leukaemia14 recruiting
- Colorectal cancer13 recruiting
- Metastatic breast cancer11 recruiting
- Liver and biliary tract cancer10 recruiting
- Prostate cancer10 recruiting
- Multiple myeloma7 recruiting
- Pancreatic cancer7 recruiting
- Triple-negative breast cancer7 recruiting
- Atrial fibrillation6 recruiting
- Bladder cancer6 recruiting
- Coronary artery disease6 recruiting
- Childhood cancers4 recruiting
- Follicular lymphoma4 recruiting
- Head and neck cancer4 recruiting
- Hepatitis B4 recruiting
- High blood pressure4 recruiting
- Mantle cell lymphoma4 recruiting
- Obstructive sleep apnoea4 recruiting
- Type 2 diabetes4 recruiting
- Kidney cancer3 recruiting
- Lupus (SLE)3 recruiting
- Stroke3 recruiting
- Type 1 diabetes3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Acute myeloid leukaemia2 recruiting
- Amyloidosis2 recruiting
- Asthma2 recruiting
- Brain aneurysm2 recruiting
- Brain metastases2 recruiting
- Chronic myeloid leukaemia2 recruiting
- COPD2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Heart failure2 recruiting
- Immune thrombocytopenia (ITP)2 recruiting
- Liver cirrhosis2 recruiting
- Obesity2 recruiting
- Ovarian cancer2 recruiting
- Primary biliary cholangitis2 recruiting
- Psoriasis2 recruiting
- Psoriatic arthritis2 recruiting
- Spinal cord injury2 recruiting
- Ventricular tachycardia2 recruiting
- ALS (motor neurone disease)1 recruiting
- Alzheimer disease1 recruiting
- Antiphospholipid syndrome1 recruiting
- Aortic aneurysm1 recruiting
- Chronic kidney disease1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Crohn's disease1 recruiting
- Graves' disease1 recruiting
- Mild cognitive impairment1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Osteoarthritis1 recruiting
- Peripheral artery disease1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
Withdrawn
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases
Completed
Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia
Completed
Completed
Completed
Completed
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors
Completed
Completed
Completed
Completed
Effect of Vericiguat on Acute Coronary Syndrome( ACS)Patients With Ejection Fraction <45%
Completed
Completed
Effect of Suanzaoren Decoction and Huanglian Wendan Decoction on Biorhythm of Insomnia Patients
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Completed
Effect of HIIT on Cardiopulmonary Function After PCI in Patients With Coronary Heart Disease
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Terminated
Completed
Omitting of Lymphadenectomy is Acceptable for Lung Cancer Smaller Than 6 mm in Solid Size
Completed
A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss
Completed
Completed
Completed
SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer
Completed
A Study of PM8002 Injection in Combination With Standard Chemotherapy as First Line Therapy in MPM
Completed
Completed
Terminated
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Withdrawn
Completed
Completed
Completed
Terminated
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Completed
Completed
Completed
Assessment of Renal Vasculature and Function with Ferumoxytol-enhanced Magnetic Resonance Imaging
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Terminated
Terminated
Terminated
Completed
Timing of Endoscopic Intervention for Acute Variceal Hemorrhage: an RCT
Completed
Completed
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Completed
New Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China
Completed
Completed
Showing 50 of 77.
Registry name variants (32)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Jiangsu Province Hospital
Nanjing, Jiangsu 210029
221 trials
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China, Jiangsu 210000
101 trials
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu 210000
8 trials
Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu 210029
5 trials
The First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital)
Nanjing, Jiangsu 210029
4 trials
Urology dpt, First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu 210029
3 trials
NCT06177015Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC
Contact: Shangqian Wang, M.D.,PhD.
Contact: Shangqian Wang, M.D.,PhD.
NCT05956639Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Contact: Shangqian Wang, M.D.,PhD.
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Nanjing, Jiangsu
2 trials
NCT07139873A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Contact: Cong Wei
NCT06539182DZD8586 in Patients With Relapsed or Refractory CLL/SLL (TAI-SHAN8)
Contact: Tianmo Sun
Nanjing Medical University (NMU) - Jiangsu Province Hospital
Nanjing, Jiangsu 210036
2 trials
Colorectal Surgery Department, First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu
1 trial
Contact: Yueming Sun
Department of Cardiology ,the First Affiliated Hospital of Nanjing Medical University
Nanjing
1 trial
Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu 210029
1 trial
Contact: Mei Zhang
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
NCT06958705Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
Contact: Jianyong Li, PhD, MD
Department of Rheumatology and Immunology, Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
First Affiliated Hospital, Nanjing Medical University
Nanjing, Jiangsu 210029
1 trial
Contact: Tao Yang, PhD
Jiangsu Province Hosp
Nanjing, Jiangsu
1 trial
Jiangsu Province Hospital
Jiangsu, 210029
1 trial
Jiangsu Province Hospital
Nanjin
1 trial
Jiangsu Province Hospital
Shanghai, Shanghai Municipality 210029
1 trial
NCT07014878A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Contact: Kuirong Jiang, PhD
Jiangsu Province Hospital
Suzhou, Jiangsu 221006
1 trial
Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital (Site 1426)
Nanjing, Jiangsu 210029
1 trial
Contact: Study Coordinator
Jiangsu Province Hospital (Site 2000)
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital (Site 2216)
Nanjing, Jiangsu 210003
1 trial
Contact: Toll Free Number
Jiangsu Province Hospital (Site 2823)
Nanjing, Jiangsu 210029
1 trial
Contact: Study Coordinator
Jiangsu Province Hospital (Site 3105)
Nanjing, Jiangsu 210029
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Study Coordinator
Jiangsu Province Hospital (Site 3507)
Nanjing, Jiangsu 210029
1 trial
Jiangsu Province Hospital (Site 5009)
Nanjing, Jiangsu 210029
1 trial
Nanjing First Hospital, Nanjing Medical University Affiliated Hospital
Nanjing, Jiangsu
1 trial
Contact: Xiaowei Wei
The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029
Nanjing, Jiangsu
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Liver and biliary tract cancer120 works · 12 trials
- Lung cancer96 works · 36 trials
- Gastric and oesophageal cancer91 works · 36 trials
- Atrial fibrillation65 works · 7 trials
- Colorectal cancer64 works · 19 trials
- Bladder cancer35 works · 8 trials
- Kidney cancer35 works · 4 trials
- Pancreatic cancer34 works · 8 trials
- Triple-negative breast cancer33 works · 16 trials
- Glioblastoma28 works · 0 trials
- Fatty liver disease (MASLD/MASH)26 works · 2 trials
- Mild cognitive impairment23 works · 1 trial
- Diffuse large B-cell lymphoma22 works · 5 trials
- Spinal cord injury20 works · 2 trials
- Psoriasis20 works · 1 trial
- Metastatic breast cancer19 works · 24 trials
- Thyroid cancer17 works · 0 trials
- Neuroendocrine tumours15 works · 1 trial
- Diabetic eye disease14 works · 0 trials
- Chronic lymphocytic leukaemia13 works · 26 trials
- Pulmonary arterial hypertension10 works · 2 trials
- Haemophagocytic lymphohistiocytosis10 works · 1 trial
- Ventricular tachycardia9 works · 2 trials
- Mesothelioma6 works · 1 trial
- Hyperparathyroidism5 works · 0 trials
- Chronic myeloid leukaemia5 works · 3 trials
- Follicular lymphoma5 works · 8 trials
- Sjögren's disease4 works · 1 trial
Institution data: ROR 04py1g812 (CC0-1.0)Updated 15 Nov 2026